» Articles » PMID: 20083660

Evidence for Molecular Mimicry Between Human T Cell Epitopes in Rotavirus and Pancreatic Islet Autoantigens

Overview
Journal J Immunol
Date 2010 Jan 20
PMID 20083660
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

In type 1 diabetes, insulin-producing beta cells in the islets of the pancreas are destroyed by autoreactive T cells. Rotavirus (RV) has been implicated in the pathogenesis of type 1 diabetes. Peptides in VP7, a major immunogenic protein of RV, have high sequence similarity to T cell epitope peptides in the islet autoantigens tyrosine phosphatase-like insulinoma Ag 2 (IA2) and glutamic acid decarboxylase 65 (GAD65). We aimed to educe evidence for the hypothesis that molecular mimicry with RV promotes autoimmunity to islet autoantigens. Peptides in RV and their sequence-similar counterparts in IA2 and GAD65 were assayed for binding to HLA molecules associated with type 1 diabetes and for the ability to elicit T cell proliferative responses in HLA-typed individuals. T cells expanded or cloned to epitopes in IA2 or RV were then tested for cross-reactivity with these epitopes. Peptides in RV-VP7, similar to T cell epitopes in IA2 and GAD65, bound strongly to HLA-DRB1*04 molecules that confer susceptibility to type 1 diabetes and were also T cell epitopes in humans at risk for type 1 diabetes. The proliferative responses of T cells to the similar peptides in RV and islet autoantigens were significantly correlated. T cells expanded to the IA2 epitope could be restimulated to express IFN-gamma by the similar peptide in RV-VP7, and T cell clones generated to this RV-VP7 peptide cross-reacted with the IA2 epitope. Our findings are consistent with the hypothesis that molecular mimicry with RV could promote autoimmunity to islet Ags.

Citing Articles

Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis.

Kosmeri C, Klapas A, Evripidou N, Kantza E, Serbis A, Siomou E Vaccines (Basel). 2025; 13(1).

PMID: 39852829 PMC: 11769441. DOI: 10.3390/vaccines13010050.


Viruses as a potential environmental trigger of type 1 diabetes mellitus (Review).

Alves Abrantes J, Verissimo de Azevedo J, Fernandes F, Almeida V, Custodio De Oliveira L, Ferreira de Oliveira M Biomed Rep. 2024; 20(5):81.

PMID: 38628629 PMC: 11019645. DOI: 10.3892/br.2024.1770.


Immunological and virological triggers of type 1 diabetes: insights and implications.

Lemos J, Hirani K, von Herrath M Front Immunol. 2024; 14:1326711.

PMID: 38239343 PMC: 10794398. DOI: 10.3389/fimmu.2023.1326711.


No association between incidence of type 1 diabetes and rotavirus vaccination in Swedish children.

Rangert A, Oldin C, Golsater M, Ludvigsson J, Akesson K Front Immunol. 2023; 14:1175071.

PMID: 37638044 PMC: 10456946. DOI: 10.3389/fimmu.2023.1175071.


Rotavirus-Associated Hospitalization in Children With Subsequent Autoimmune Disease.

Ha E, Kim J, Cha H, Lee G, Shin J, Shin Y JAMA Netw Open. 2023; 6(7):e2324532.

PMID: 37494043 PMC: 10372702. DOI: 10.1001/jamanetworkopen.2023.24532.